Search tips
Search criteria 


Logo of pharmscispringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSci. 2004 March; 6(1): 22–30.
Published online 2015 July 10. doi:  10.1208/ps060103
PMCID: PMC2750938

Solvation and hydration characteristics of ibuprofen and acetylsalicylic acid


Ibuprofen and acetylsalicylic acid were studied by thermoanalytical methods: sublimation calorimetry, solution calorimetry, and with respect to solubility. Upon measuring the temperature dependences of the saturated vapor pressure, enthalpies of sublimation, ΔHsub0, as well as the entropies of sublimation, ΔHsub0, and their respective relative fractions in the total process were calculated. The Gibbs energy of solvation in aliphatic alcohols as well as the enthalpic and entropic fractions thereof were also studied and compared with the respective properties of model substances and other nonsteroidal antiinflammatory drugs (benzoic acid, diflunisal, flurbiprofen, ketoprofen, and naproxen). In all cases, enthalpy was found to be the driving force of the solvation process. Correlations were derived between Gibbs energy of solvation in octanol, ΔGsolvOct, and the transfer Gibbs energy from water to octanol, ΔGtr0. Influence of mutual octanol and water solubilities on the driving force of partitioning is discussed. An enthalpy-entropy-compensation effect in octanol was observed, and consequences of deviation from the general trend are also discussed.

Keywords: ibuprofen, acetylsalicylic acid, NSAID, sublimation, solvation, hydration, plasma half-life


1. Steyeart G, Lisa G, Gaillard P, et al. Intermolecular forces expressed in 1,2-dichloroethane-water partition coefficients. J Chem Soc, Faraday Trans 1. 1997;93:401–406. doi: 10.1039/a606374h. [Cross Ref]
2. Johnson ME, Blankschtein D, Langer R. Evaluation of solute permeation through the stratum corneum: Lateral bilayer diffusion as the primary transport mechanism. J Pharm Sci. 1997;86:1162–1172. doi: 10.1021/js960198e. [PubMed] [Cross Ref]
3. Perlovich GL, Bauer-Brandl A. Thermodynamics of solutions I: Benzoic acid and acetylsalicylic acid as models for drug substances and the prediction of solubility. Pharm Res. 2003;20:471–478. doi: 10.1023/A:1022624725495. [PubMed] [Cross Ref]
4. Perlovich GL, Kurkov SV, Bauer-Brandl A. Thermodynamics of solutions II: Flurbiprofen and diflunisal as models for studying solvation of drug substances. Eur J Pharm Sci. 2003;19:423–432. doi: 10.1016/S0928-0987(03)00145-3. [PubMed] [Cross Ref]
5. Perlovich GL, Kurkov SV, Kinchin AN, Bauer-Brandl A. Thermodynamics of solutions III: Comparison of the solvation of (+)-Naproxen with other NSAIDs. Eur J Pharm Biopharm. In press. [PubMed]
6. Perlovich GL, Kurkov SV, Kinchin AN, Bauer-Brandl A. Thermodynamics of solutions IV: Comparison of the solvation of Ketoprofen with other NSAIDs. J Pharm Sci. 2003;92(12):2511–2520. doi: 10.1002/jps.10512. [PubMed] [Cross Ref]
7. Zielenkiewicz W, Golankiewicz B, Perlovich GL, Kozbial M. Aqueous solubilities, infinite dilution activity coefficients and octanol-water partition coefficients of tricyclic analogues of acyclovir. J Solution Chem. 1999;28:731–745. doi: 10.1023/A:1021720128725. [Cross Ref]
8. Kinchin AN, Kolker AM, Krestov GA. Calorimeter without liquid thermostatical shell for determination of heat effects at low temperatures. Rus J Phys Chem. 1986;60:782–783.
9. Cox JD, Pilcher G. Thermochemistry of Organic and Organometallic Compounds. London, UK: Academic Press; 1970.
10. Zielenkiewicz W, Perlovich G, Wszelaka-Rylik M. The vapour pressure and the enthalpy of sublimation determination by inert gas flow method. J Thermal Analysis and Calorimetry. 1999;57:225–234. doi: 10.1023/A:1010179814511. [Cross Ref]
11. Perlovich GL, Kurkov SV, Hansen LK, Bauer-Brandl A. Thermodynamics of sublimation, crystal lattice energies and crystal structures of racemates and enantiomers: (+)- and (±)-Ibuprofen. J Pharm Sci. In press. [PubMed]
12. Li ZJ, Ojala WH, Grant DJW. Molecular modeling study of chiral drug crystals: Lattice energy calculations. J Pharm Sci. 2001;90:1523–1539. doi: 10.1002/jps.1103. [PubMed] [Cross Ref]
13. Barbato F, La Rotonda MI, Quaglia F. Interaction of nonsteroidal anti-inflammatory drugs with phospholipids: Comparison between octanol/buffer partition coefficients and chromatographic indexes on immobilized artificial membranes. J Pharm Sci. 1997;86:225–229. doi: 10.1021/js960233h. [PubMed] [Cross Ref]
14. Tomlinson E. Enthalpy-entropy compensation analysis of pharmaceutical, biochemical and biological systems. Int J Pharm. 1983;13:115–144. doi: 10.1016/0378-5173(83)90001-7. [Cross Ref]
15. Perlovich GL, Brandl-Bauer A. The melting process of acetylsalicylic acid single crystals. J Thermal Analysis and Calorimetry. 2001;63:653–661. doi: 10.1023/A:1010119532614. [Cross Ref]
16. Perlovich GL, Kurkov SV, Bauer-Brandl A. Thermodynamics of sublimation and crystal lattice energies of racemates and enantiomers: (+)- and (±)-Ibuprofen. J Pharm Sci. In press. [PubMed]
17. Yang G, Ran Y, Yalkowsky SH. Prediction of the aqueous solubility: Comparison of the general solubility equation and the method using an amended solvation energy relationship. J Pharm Sci. 2002;91:517–533. doi: 10.1002/jps.10022. [PubMed] [Cross Ref]
18. Yalkowsky SH, Valvani SC, Roseman TJ. Solubility and partitioning VI: Octanol solubility and octanol-water partition coefficients. J Pharm Sci. 1983;72:866–870. doi: 10.1002/jps.2600720808. [PubMed] [Cross Ref]
19. Cotton M, Hux R. Diflunisal. In: Florey K, editor. Analytical Profiles of Drug Substances. Vol 14. London, UK: Academic Press; 1985. pp. 491–526.
20. Kommury TR, Khan MA, Reddy IK. Racemate and enantiomers of ketoprofen: Phase diagram, thermodynamic studies, skin permeability, and use of chiral permeation enhancers. J Pharm Sci. 1998;87:833–840. doi: 10.1021/js9704644. [PubMed] [Cross Ref]
21. Bergström CAS, Norinder U, Luthman K, Artursson P. Experimental and computational screening models for prediction of aqueous drug solubility. Pharm Res. 2002;19:182–188. doi: 10.1023/A:1014224900524. [PubMed] [Cross Ref]

Articles from AAPS PharmSci are provided here courtesy of American Association of Pharmaceutical Scientists